Key Takeaways
- Domestic B2C drove a 7% revenue quarter to ₹1,022 cr, with Crop Care domestic up 19% by volume, while exports fell 28% on weak demand and logistics snarls.
- A ₹35 cr employee cost reversal flattered the P&L, of which ₹24 cr is a one-time restructuring item that will not repeat.
- Price increases are finally sticking after months of market resistance, but the full benefit will only be clear at season end, and volume remains the priority.
- The seed business is deliberately pivoting away from cotton toward higher-margin rice, maize and millet, a mix shift that already lifted seed EBITDA margin from 26% to 30%.
- What to watch next quarter: Whether the delayed monsoon triggers a catch-up in sowing and spray that lifts volumes, the scale of crop protection returns taken back in Q2, and any escalation in the Middle East conflict that re-inflates raw material and freight costs.
Domestic Demand & the Monsoon Gamble
- Delayed rain, delayed sowing, delayed spraying: The monsoon arrived late, compressing the kharif window and deferring placements. Management believes a catch-up is underway, with pulses area up, rice on track, and maize getting planted despite early concerns.
- Cotton acreage is falling, but the spray story may hold: North cotton (Punjab, Haryana) saw significant area decline; South and Central face rain-fed issues and illegal HTBT spread. Even so, intermittent rain and supportive cotton prices could mean farmers who planted still execute field operations, limiting the net impact.
- Channel inventory has normalized after a worrisome period a month ago. A shift in herbicide demand is visible: less pre-emergent in soybean, more post-emergent, reflecting the compressed sowing window.
- Crop switching reshapes the product mix: Cotton area down, soybean and maize up, pulses up. Soybean planting increases herbicide consumption but reduces insecticide and fungicide use; cotton does the reverse. The net effect on Rallis depends on where its portfolio strength lies.
- Working capital stretched industry-wide: Fertilizer shortages forced farmers to block cash into fertilizer first, rationing spend on other agri inputs. Rallis saw a 15-20 day increase in working capital, a sector-wide phenomenon, not company-specific.
Gyanendra Shukla: "I wouldn't be very pessimistic at this point of time. I would say sometimes good distribution of rain even if it's marginally lower, even if 90%, 95% of the normal cotton acres get planted, might still lead to a similar situation as last year."
Exports: A Sharp, Multi-Factor Decline
- Exports de-grew 28% on a 35% volume decline, driven by three distinct headwinds: lower European demand for pendimethalin, aggressive Chinese pricing on Acephate, Pendi CS and Hexaconazole, and shipping delays from port congestion and logistical uncertainty.
- CSM was the bright spot, with revenue up 191% to ₹24 cr on a rebound in PEKK sales volumes. First shipments of a new product for a US customer were well received on quality.
- Catalogue exports remain a price-taker's game: Management acknowledged that for catalogue products, competitiveness is non-negotiable, while CSM contracts allow negotiation with counterparties.
- Rupee depreciation was a net positive for Rallis as a net exporter, adding to profitability despite the lower export volumes.
Gyanendra Shukla: "As far as CSM is concerned, where you have a contract with the company. I think it is okay, still fine because you can discuss with the counterparty and negotiate terms and conditions. As far as catalogue products are concerned, I think we have to remain competitive."
Price Increases: From Announcement to Acceptance
- Rallis was first to announce price increases, but the market did not accept them until May end. Only after old inventory liquidated in June did the increases become a reality. The reported numbers already combine volume and price effects.
- Pass-through was uneven: full cost increase passed on in some products, partial in others, none in some. On an overall basis, management expects a marginal positive impact from price.
- Pre-buying provided a hedge: The company procured inventory early (February/March) anticipating war-driven price hikes, securing kharif supply and negotiating better discounts due to its cash position. The full benefit will only be quantifiable at season end.
- Raw material prices are trending toward normal after an MOU between two nations about a month ago. Enough inventory exists for kharif, so no panic buying. For rabi procurement starting in August, higher prices may be unavoidable if the geopolitical situation persists.
- Volume remains the strategic priority: Management will strike a balance between volume and price but will give precedence to volume if forced to choose after the season.
Gyanendra Shukla: "our priority will remain to strike a fine balance between volume and price, but give a precedence to volume if you have to make it after season."
Seeds: A Deliberate Cotton Exit, Margin Tailwind
- Seed EBITDA margin rose from 26% to 30% driven purely by product mix: cotton (lower margin due to government price control) declined as a share, while rice, maize and millet (higher margin) increased.
- Cotton seed is being proactively shrunk: Management reduced its own cotton seed production acreage this year, knowing every company will carry forward inventory sufficient for 30-50% of next year's requirement. The strategic focus is now on five crops: Cotton, Maize, Millet, Mustard, and Rice.
- Yield gains were neutralized by post-harvest costs: Higher field yields were offset by a gas crisis during harvest (war began end of February) that forced open-field "pad drying," reducing recovery. The net math is still in progress.
- Rice, maize and millet are the growth heroes for the year, supported by new product launches. Mustard may also contribute if oilseed prices stay elevated. Diversification is the structural advantage.
- Seed production risk is unknowable until October: If there is significant failure of cotton seed production in the current October-November planting season, it could become a challenge. Management was explicit that nobody can predict this.
Gyanendra Shukla: "I can tell you in my more than 3 decades of career, nobody has been able to predict the future in this."
Margins: A One-Time Tailwind Masks the Underlying
- A ₹35 cr employee cost reversal boosted the quarter: ₹10-11 cr is a recurring Q1 performance incentive adjustment that happens every year; ₹24 cr is a one-time restructuring/retiral item specific to this year and not likely to repeat.
- Other expenses also carried one-time costs that may not be repetitive, further clouding the underlying margin picture.
- Returns provisioning is being deliberately conservative: Management is using an AI-driven model plus dealer and customer feedback to provision more rather than less this year, acknowledging uncertainty with "How much enough that is going to be enough, I don't know."
- The 500 bps EBITDA margin ambition over 5 years remains the stated goal. Management wants to be a company that delivers 15% plus EBITDA margin even in a bad year, building consistency and stability into the earnings profile.
Gyanendra Shukla: "We want to be a consistent company, which delivers 15% plus EBITDA margin even in a bad year. So that kind of consistency and stability we want to bring in."
Portfolio Shifts & Competitive Positioning
- Herbicide completed a two-year turnaround: Two years ago it was a stated weakness; this quarter it became the largest contributor in crop protection, growing 12%, ahead of insecticide and fungicide. New products including a rice herbicide and participation in direct seeded rice technology via in-licensing drove the shift.
- Biologicals are expected to do significantly better than last year, aided by positive regulatory developments (modernized biostimulant framework under FCO) that remove portfolio challenges. It remains a smaller but more profitable segment.
- The unorganized sector is under working-capital stress, and management sees an opportunity for organized players like Rallis to capture share. The larger industry challenge is cash getting stuck in the fertilizer channel.
- Brand is the biggest strength, but management acknowledged brand alone will not be enough and is actively working on the portfolio.
- Digital engagement is scaling: The Anubandh Edge retailer platform crossed 56,000 registrations; Sampark+ is capturing farmer-level demand signals; the Idea2Impact platform received ~40 applications with 2 in pilot stage.
Gyanendra Shukla: "2 years ago, I said that, look, our herbicide is our weakness, and we have started adding products. But as we speak this year, if you say this quarter, just this quarter, actually, herbicide is our largest contributor followed by insecticide and fungicide."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| EBITDA margin aspiration | Deliver 15% plus EBITDA margin even in a bad year; 500 bps improvement over 5 years | 5-year horizon |
| Crop protection domestic industry growth | Industry expected to grow 6-8% this year, driven by price increases | FY27 |
| Seeds growth ex-cotton | Mid- to high single digits; cotton is a challenging year | FY27 |
| Biologicals performance | Expected to do significantly better than last year as sowing picks up | FY27 |
| Chilli recovery | Positive planting intentions and high commodity prices should help domestic Crop Care; impact in Q2 and Q3 | Q2-Q3 FY27 |
| Volume clarity | Management will have a better picture on whether volumes are flattish or show marginal degrowth | Mid-August |
| Returns provisioning | More cautious accounting for returns this year, provisioning more rather than less | FY27 |
| Cotton seed production risk | If significant failure occurs in October-November planting, it could become a challenge; knowable only in Oct-Dec | Oct-Dec FY27 |
Key Metrics
| Metric | Q1 FY27 |
|---|---|
| Revenue | ₹1,022 cr, +7% YoY from ₹957 cr |
| EBITDA | ₹184 cr, +23% YoY from ₹150 cr |
| Profit after tax | ₹125 cr, +31% YoY from ₹95 cr |
| Exceptional items | ₹2 cr profit on sale of a property |
| Overall volume growth | ~2% |
| Overall pricing growth | ~5% |
| Crop Care segment revenue | ₹697 cr, +7% YoY; volume growth 2%, price growth 5% |
| Domestic Crop Care (B2C) revenue | ₹534 cr, +19% YoY; volume growth 15% |
| Crop Protection category revenue | ₹455 cr, +18% YoY; volume growth 16% |
| Soil & Plant Health category revenue | ₹62 cr, +10% YoY; price growth 13% |
| Exports revenue | ₹110 cr, -28% YoY; volume de-growth 35% |
| CSM revenue | ₹24 cr, +191% YoY from ₹8 cr |
| Total B2B revenue | ₹163 cr, -19% YoY; volume de-growth 26% |
| Seeds segment revenue | ₹325 cr, +6% YoY; price growth 6% |
| Seeds segment EBITDA margin | 30%, up from 26% YoY |
| Cash and liquid balance | ₹309 cr as of June 30, 2026 |
| Working capital days | Increased by 15 to 20 days YoY |
| Herbicide business growth | 12% in Q1; now largest contributor in crop protection |
| Biologicals segment growth | 10% in Q1 |
| Retailer registrations (Anubandh Edge) | 56,000+ as of June end |
| New crop care products launched | 4 (Balwan, Prodim Ultra, Kengen, Aquafert Ginger & Turmeric) |
| New seeds products launched | 9 across Cotton, Millet and Paddy |
| India seasonal rainfall | ~15% below normal as of July 8, 2026 |
| Kharif sowing area | ~32% of normal by July 5, 2026; still ~21% lower YoY |
| Reservoir storage | 34.46% by July 16, 2026; ~98% of 10-year normal |
| FY27 agrochemicals industry growth outlook | ~6–8% in India |
| Global crop protection market size | ~USD 70-80 bn in CY2026, expected 4.5–6.5% CAGR |
| Management EBITDA margin aspiration | 15%+ even in a bad year |
| Employee cost provision reversal | ₹35 cr in Q1; ₹24 cr onetime restructuring/retiral, ₹11 cr recurring performance incentive reversal |
| Like-to-like employee cost increase | ~12% YoY, normal inflation |
| Other expenses increase | ~13-14% YoY |